| Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms E Ruffini, S Asioli, PL Filosso, P Lyberis, MC Bruna, L Macrì, L Daniele, ... The Annals of thoracic surgery 87 (2), 365-372, 2009 | 185 | 2009 |
| Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical … S Asioli, LA Erickson, TJ Sebo, J Zhang, L Jin, GB Thompson, RV Lloyd The American journal of surgical pathology 34 (1), 44-52, 2010 | 175 | 2010 |
| Extending the phenotypes associated with DICER1 mutations WD Foulkes, A Bahubeshi, N Hamel, B Pasini, S Asioli, G Baynam, ... Human mutation 32 (12), 1381-1384, 2011 | 163 | 2011 |
| Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers S La Rosa, V Adsay, L Albarello, S Asioli, S Casnedi, F Franzi, A Marando, ... The American journal of surgical pathology 36 (12), 1782-1795, 2012 | 146 | 2012 |
| Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression S Asioli, LA Erickson, A Righi, L Jin, M Volante, S Jenkins, M Papotti, ... Modern Pathology 23 (9), 1269-1278, 2010 | 135 | 2010 |
| p63 expression as a new prognostic marker in Merkel cell carcinoma S Asioli, A Righi, M Volante, V Eusebi, G Bussolati Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 121 | 2007 |
| Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas D Buehler, H Hardin, W Shan, C Montemayor-Garcia, PS Rush, S Asioli, ... Modern Pathology 26 (1), 54-61, 2013 | 89 | 2013 |
| The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression H Hardin, Z Guo, W Shan, C Montemayor-Garcia, S Asioli, XM Yu, ... The American journal of pathology 184 (8), 2342-2354, 2014 | 85 | 2014 |
| Adenosquamous lung carcinomas: a histologic subtype with poor prognosis PL Filosso, E Ruffini, S Asioli, R Giobbe, L Macri, MC Bruna, A Sandri, ... Lung Cancer 74 (1), 25-29, 2011 | 83 | 2011 |
| Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior S Asioli, LA Erickson, A Righi, RV Lloyd Human pathology 44 (3), 320-328, 2013 | 77 | 2013 |
| Expression of p63 is the sole independent marker of aggressiveness in localised (stage I–II) Merkel cell carcinomas S Asioli, A Righi, D De Biase, L Morandi, V Caliendo, F Picciotto, ... Modern Pathology 24 (11), 1451-1461, 2011 | 75 | 2011 |
| Outcome and prognostic factors in bronchial carcinoids: a single-center experience PL Filosso, A Oliaro, E Ruffini, G Bora, P Lyberis, S Asioli, L Delsedime, ... Journal of Thoracic Oncology 8 (10), 1282-1288, 2013 | 71 | 2013 |
| The role of epithelial mesenchymal transition markers in thyroid carcinoma progression C Montemayor-Garcia, H Hardin, Z Guo, C Larrain, D Buehler, S Asioli, ... Endocrine pathology 24 (4), 206-212, 2013 | 65 | 2013 |
| Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia-related bleeding in patients with liver cirrhosis L Fuccio, RM Zagari, M Serrani, LH Eusebi, D Grilli, V Cennamo, ... Digestion 79 (3), 143-150, 2009 | 60 | 2009 |
| APC alterations are frequently involved in the pathogenesis of acinar cell carcinoma of the pancreas, mainly through gene loss and promoter hypermethylation D Furlan, N Sahnane, B Bernasconi, M Frattini, MG Tibiletti, F Molinari, ... Virchows Archiv 464 (5), 553-564, 2014 | 58 | 2014 |
| Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells MG Catalano, N Fortunati, M Pugliese, F Marano, L Ortoleva, R Poli, ... The Journal of Clinical Endocrinology & Metabolism 97 (7), E1150-E1159, 2012 | 56 | 2012 |
| Significance of the presence of microscopic vascular invasion after complete resection of stage I–II pT1-T2N0 non-small cell lung cancer and its relation with T-size categories … E Ruffini, S Asioli, PL Filosso, L Buffoni, MC Bruna, C Mossetti, P Solidoro, ... Journal of Thoracic Oncology 6 (2), 319-326, 2011 | 55 | 2011 |
| Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo MG Catalano, M Pugliese, E Gargantini, C Grange, B Bussolati, S Asioli, ... International journal of cancer 130 (3), 694-704, 2012 | 53 | 2012 |
| Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells M Pugliese, N Fortunati, A Germano, S Asioli, F Marano, N Palestini, ... Thyroid 23 (7), 838-846, 2013 | 49 | 2013 |
| Papillary thyroid carcinoma J Rosai, J Albores Saavedra, S Asioli, ZW Baloch, T Bogdanova, H Chen, ... WHO classification of tumours of endocrine organs 10, 81-91, 2017 | 48 | 2017 |
alberto righiIstituto Ortopedico RizzoliVerified email at ior.it
